Lezli Braswell
Family Medicine · Flower Mound, TXNPI 1194722876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 24.7% of the total. Reporting peaked in 2021 at $1,778 and has fallen 94.6% since, to $96 in 2025.
Across 229 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$896
- Novo Nordisk$732
- AstraZeneca$386
- Lilly USA, LLC$289
- Bayer$220
- Esperion Therapeutics, Inc.$187
- plus $923 from 18 others
What the payments were for
- Food & beverage$3,627100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 58 | $896 |
| Novo Nordisk | 55 | $732 |
| AstraZeneca | 22 | $386 |
| Lilly USA, LLC | 20 | $289 |
| Bayer | 12 | $220 |
| Esperion Therapeutics, Inc. | 13 | $187 |
| Biohaven Pharmaceuticals, Inc. | 5 | $112 |
| Amarin Pharma, Inc. | 6 | $101 |
| Galderma Laboratories, L.p. | 1 | $96 |
| GSK | 6 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $88 |
| Novartis | 5 | $75 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Boehringer Ingelheim | 4 | $60 |
| Eisai Inc. | 3 | $44 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Abbott | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Merck | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$3,634 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Flower Mound
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.